KDR and cancer: There is increasing evidence that MRC2 interferes with lymphatic endothelial cells VEGFR-2 and VEGFR-3, which are associated with cancer progression and metastasis to lymph nodes and distant organs (Cady, 2007; Paupert et al., 2011; Durre et al., 2018).